Prot #1951-CL-0101: A Phase 1b Study of ASP1951, a GITR Agonistic Antibody, as a Single Agent and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date11/11/207/23/24

Funding

  • INC Research, LLC ((OE) Prot #1951-CL-0101 // (OE) Prot #1951-CL-0101)
  • Astellas Pharma Global Development, Inc. ((OE) Prot #1951-CL-0101 // (OE) Prot #1951-CL-0101)